Predictive modeling of ALS progression: an XGBoost approach using clinical features

Area of Science:

• Neurology
• Biomedical Engineering
• Data Science

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease.
• Accurate prediction of ALS progression is crucial for patient management.
• Existing methods may not fully capture the nuances of disease trajectory.

Purpose of the Study:

• To develop and validate a predictive model for ALS progression.
• To utilize clinical features for forecasting functional decline.
• To provide a tool for enhanced patient management and treatment strategies.

Main Methods:

• A dataset of 50 ALS patients was analyzed.
• Clinical features including speech, mobility, and respiratory function were evaluated.
• An XGBoost regression model was employed to predict ALSFRS-R scores.

Main Results:

• The XGBoost model achieved high accuracy.
• Training Mean Squared Error (MSE) was 0.1651; testing MSE was 0.0073.
• R² values were 0.9800 for training and 0.9993 for testing, indicating strong predictive power.

Conclusions:

• The developed model accurately estimates ALS progression.
• This tool can assist clinicians in tracking disease trajectory.
• Improved disease monitoring can lead to better patient outcomes and treatment optimization.